Ranjitkar Manandhar, N., Kayastha, G. K., & Acharya, P. K. (2018). Dasatinib tyrosine kinase inhibitor as second and third line therapy in chronic myeloid leukemia: outcome of a Nepalese study. Journal of Patan Academy of Health Sciences, 5(1), 47–56. Retrieved from https://jpahs.edu.np/index.php/jpahs/article/view/97